DAWN - Day One Biopharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

DAWN is currently covered by 6 analysts with an average price target of $24. This is a potential upside of $2.47 (11.47%) from yesterday's end of day stock price of $21.53.

Day One Biopharmaceuticals's activity chart (see below) currently has 107 price targets and 86 ratings on display. The stock rating distribution of DAWN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 8.65% of the time, taking 35.22 days on average.

Highest price target for DAWN is $34, Lowest price target is $21.5, average price target is $24.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 11-Mar-2026. First documented stock forecast 21-Jun-2021.

Currently out of the existing stock ratings of DAWN, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Jun-2021

$21.5

$-0.03 (-0.14%)

$27

8 months 11 days ago
(11-Mar-2026)

1/7 (14.29%)

$0.25 (1.18%)

42

Buy Since 15-Dec-2022

$21.5

$-0.03 (-0.14%)

$22

8 months 12 days ago
(10-Mar-2026)

1/19 (5.26%)

$0.22 (1.03%)

43

Buy Since 21-Jun-2021

$21.5

$-0.03 (-0.14%)

$30

8 months 13 days ago
(09-Mar-2026)

1/10 (10%)

$0.17 (0.80%)

44

Buy Since 14-Dec-2022

$17

8 months 16 days ago
(06-Mar-2026)

3/20 (15%)

$6.07 (55.54%)

108

Buy Since 27-Feb-2024

$21.5

$-0.03 (-0.14%)

$20

8 months 16 days ago
(06-Mar-2026)

2/6 (33.33%)

$0.3 (1.42%)

80

Show more analysts

Please expand the browser size to see the chart

What is DAWN (Day One Biopharmaceuticals) average time for price targets to be met?

On average it took 35 days for the stock forecasts to be reached, with an average price target met ratio of 8.65%.

Which analyst most recently updated their price target on DAWN (Day One Biopharmaceuticals)?

Anupam Rama

Which analyst has the lowest performance score on DAWN (Day One Biopharmaceuticals) with a proven track record?

TARA BANCROFT

Which analyst has the most public recommendations on DAWN (Day One Biopharmaceuticals)?

Anupam Rama works at JPMORGAN and has 36 price targets and 21 ratings on DAWN

Which analyst is the currently most bullish on DAWN (Day One Biopharmaceuticals)?

Joseph Catanzaro with the highest potential upside of $18.47

Which analyst is the currently most reserved on DAWN (Day One Biopharmaceuticals)?

Robert Driscoll with the lowest potential downside of -$0.03
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?